SCHEMBL26835295

SCHEMBL26835295

CC(=O)N1CCN(C(=O)c2ccccc2C)C(C)C1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.54
▸ LMNA P02545 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ PIK3CD O00329 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ CPS1 P31327 1/20 0.45
▸ GHSR Q92847 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26814607 0.85 HTT (0.50) HTTLMNAALOX15TSHRHSD17B10
SCHEMBL6279963 0.83 PIK3CD (0.57) HTTALDH1A1CYP2C9CYP2C19CYP3A4
SCHEMBL26828135 0.81 HTT (0.60) HTTLMNAALOX15TSHRHSD17B10
SCHEMBL22054767 0.78 KMT2A (0.59) HTTTSHRALDH1A1CYP2C9CYP2C19
SCHEMBL26835550 0.77 L3MBTL1 (0.59) HTTLMNAALOX15TSHRHSD17B10
SCHEMBL26827907 0.77 HSD17B10 (0.85) HTTLMNAALOX15TSHRHSD17B10
SCHEMBL3455900 0.77 KMT2A (0.65) HTTLMNATSHRALDH1A1HPGD
SCHEMBL26827904 0.75 MAPT (0.50) TSHRL3MBTL1ALDH1A1CYP2C9CYP2C19
SCHEMBL10722320 0.75 HTT (0.89) HTTTSHRHSD17B10ALDH1A1CYP2C9
SCHEMBL26835548 0.75 CPS1 (0.54) HTTLMNAALOX15TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators PDE4A, PDE4B, PDE5A HTT 4024/4885LMNA 4118/4885ALOX15 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback